Sirona Biochem Announces Exceptional Clinical Trial Results for Anti-Aging Compound TFC-1326

Stock Information for Sirona Biochem Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Sirona Biochem Corp.

Sirona Biochem Update to Shareholders on Financial Status and Operations
Sirona Biochem Announces Debenture Financing
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report
Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology
SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout
GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
Sirona Biochem Engages Stonegate Healthcare Partners

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.